Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s54, 2020. DOI: 10.25251/skin.4.supp.53. Disponível em: https://skin.dermsquared.com/skin/article/view/998. Acesso em: 15 jun. 2025.